Atlas

Form 483

Oxalis Labs Form 483, 2019-08-02

FDA issued a Form 483 to Oxalis Labs on 2019-08-02 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

Oxalis Labs · Solan, India · Issued August 2, 2019

Overview

  • 4 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

2 Aug 2019
21 CFR 211.192

No written record of investigation

Cited by Jeffrey P Raimondi

2 Aug 2019
21 CFR 211.192

No written record of investigation

Cited by Jeffrey P Raimondi

2 Aug 2019
21 CFR 211.25(c)

Inadequate number of personnel

Cited by Jeffrey P Raimondi

2 Aug 2019
21 CFR 211.25(c)

Inadequate number of personnel

Cited by Jeffrey P Raimondi

Inspected site

OLOxalis LabsSolan, India

Inspection team

JPJeffrey P Raimondi

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations2x
21 CFR 211.25(c)Cited across public-safe Form 483 observations2x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Book a demoStart a free trial

Full 483 report

Get the verbatim text of all 4 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere